Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1976 - 2000 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Diacylglycerophosphoinositolglycans LMGP15010239
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/16:2(9Z,12Z))
126457607 1654.774308 C74H127O38P
LMSL03001283
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-hexatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457724 1320.981127 C73H140O17S
LMSL03001294
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457735 1320.981127 C73H140O17S
Gangliosides LMSP0601DC06
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262577 1454.922488 C73H134N2O26
Gangliosides LMSP0601DG06
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • KDN-GM2(d18:1/26:0)
44262609 1454.922488 C73H134N2O26
Diacylglycerophosphoinositolglycans LMGP15010198
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(16:0/18:0)
126457566 1648.821258 C73H133O38P
Diacylglycerophosphoinositolglycans LMGP15010207
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:0/16:0)
126457575 1648.821258 C73H133O38P
Gangliosides LMSP0601CI05
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
52931293 1483.912652 C73H133N3O27
Gangliosides LMSP0601AM05
  • GM2(d18:1/24:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262064 141451 1467.917737 C73H133N3O26
Gangliosides LMSP0601EK05
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262832 1467.917737 C73H133N3O26
Gangliosides LMSP0601DD03
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262582 1532.881413 C73H132N2O31
Gangliosides LMSP0601DF03
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • KDN-GM1(d18:1/20:0)
44262598 1532.881413 C73H132N2O31
Gangliosides LMSP0601EB03
  • KDN-lactotetraosylceramide(d18:1/20:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262758 1532.881413 C73H132N2O31
Gangliosides LMSP0601EC03
  • KDN(2-6)lactotetraosylceramide(d18:1/20:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262766 1532.881413 C73H132N2O31
Gangliosides LMSP0601GE03
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263166 1532.881413 C73H132N2O31
Gangliosides LMSP0601GG03
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/20:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263182 1532.881413 C73H132N2O31
Gangliosides LMSP0601DC08
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262579 1452.906838 C73H132N2O26
Gangliosides LMSP0601DG08
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • KDN-GM2(d18:1/26:1(17Z))
44262611 1452.906838 C73H132N2O26
Diacylglycerophosphoinositolglycans LMGP15010199
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(16:0/18:1(9Z))
126457567 1646.805608 C73H131O38P
Diacylglycerophosphoinositolglycans LMGP15010208
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:0/16:1(9Z))
126457576 1646.805608 C73H131O38P
Diacylglycerophosphoinositolglycans LMGP15010213
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:1(9Z)/16:0)
126457581 1646.805608 C73H131O38P
Gangliosides LMSP0601BY02
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262365 1561.871577 C73H131N3O32
Gangliosides LMSP0601CJ02
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262437 1561.871577 C73H131N3O32
Gangliosides LMSP0601FF02
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262981 1561.871577 C73H131N3O32
Gangliosides LMSP0601AH02
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262021 1545.876662 C73H131N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024